Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers

Inclusion Criteria: * Healthy adult males aged between 20 and 45 years * Subjects whose weight is 50 kg or more and BMI is between 18 and 29 kg/m2 * Subjects who were voluntarily decided to participate in the study and provided written informed consent to observe the directions Exclusion Criteria: * Medical history which may influence adsorption, distribution, metabolism, excretion of the drug * Clinically significant active chronic disease(s) * Persons who are deemed ineligible for the study by the investigator according to the clinical laboratory test results or for other reasons